Please visit our MS learning channel on Youtube, which provides hundreds of topics from our education programs, that were video-recorded and archived here: www.youtube.com/msviewsandnews -- Be empowered with MS news by registering with us: www.register.msviewsandnews.org

joomla ecommerce template -- Scroll left side of this blog for needed resources. Also, use our 'search by topic' tool, to find specific information.

Disclaimer: 'MS Views and News' DOES NOT endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.

============================================================

Thursday, May 18, 2017

OhioHealth hospital was the first to use the FDA Approved Drug, Ocrevus


                                                                  
  
Click here to receive MS news via e-mail




Medical staff at OhioHealth's Neuroscience Center at Riverside Methodist Hospital became the first in the world to treat patients with a new FDA drug called Ocrevus in the battle against multiple sclerosis.
The significance of the drug lies in how it can slow what's called primary progressive multiple sclerosis. The manufacturer, Genentech, says it is the first and only disease-modifying therapy for primary progressive multiple sclerosis or PPMS.
Read more




MS Views and News is MAKING an IMPACT on those affected by Multiple Sclerosis
MS Views and News provides beneficial information for those affected by Multiple Sclerosis.  
Join us by registering here: www.register.msviewsandnews.org 

No comments: